ARS Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $41.3M | $50.8M | $71.0M | $210.5M | $60.1M | $386.6M | $10.5M |
| Accounts Receivable | $25.3M | $8.2M | $0 | — | — | — | — |
| Inventory | $31.4M | $10.5M | $0 | — | — | — | — |
| Total Current Assets | $284.9M | $334.3M | $231.7M | $277.7M | $60.7M | $390.7M | — |
| Property, Plant & Equipment | $2.5M | $1.1M | $574.0K | $329.0K | $72.0K | $1.6M | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $14.5M | $7.4M | $0 | — | — | — | — |
| Total Assets | $327.7M | $351.2M | $233.2M | $281.4M | $61.4M | $394.8M | — |
| Liabilities | |||||||
| Accounts Payable | $5.7M | $9.9M | $759.0K | $1.7M | $1.8M | $2.6M | — |
| Total Current Liabilities | $39.1M | $23.4M | $2.4M | $5.4M | $8.2M | $9.6M | — |
| Long-Term Debt | $96.4M | $0 | — | — | — | — | — |
| Total Liabilities | $213.4M | $94.4M | $2.4M | $8.5M | $16.7M | $11.9M | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-294.6M | $-123.3M | $-131.3M | $-76.9M | $-42.3M | $-96.7M | — |
| Total Stockholders' Equity | $114.3M | $256.8M | $230.8M | $272.9M | $-31.3M | $-14.1M | $-58.8M |